Knee Arthroplasty Activity Trial
Launched by BRIGHAM AND WOMEN'S HOSPITAL · Sep 26, 2019
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The Knee Arthroplasty Activity Trial (KArAT) is studying ways to help people who have had total knee replacement surgery become more physically active after their operation. Although knee replacement surgery can reduce pain and improve movement, many patients don’t move around as much afterward as they did before the surgery. This trial aims to see if adding different types of support—like activity trackers and motivational coaching—can encourage patients to be more active and improve their overall quality of life.
To participate, you need to be between 40 and 85 years old, speak English, and be scheduled for a total knee replacement due to knee osteoarthritis. You'll also need to show that you can wear an activity tracker before your surgery. Participants will receive standard post-surgery care, and some will be given extra tools to help them track their activity and stay motivated. The trial is currently recruiting, and everyone involved will help researchers understand how to better support knee replacement patients in leading active lives.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 40-85 years
- • English-speaking
- • Scheduled to undergo primary, unilateral total knee replacement (TKR) at one of the 4 recruitment centers
- • OA is principal underlying indication for TKR
- • During an accelerometer run-in period lasting one week at baseline (prior to surgery), subjects must show that they can comply with waist-worn physical activity tracker protocols by wearing the activity tracker for ≥4/7 days of the week for ≥10 hours/day
- • Regular access to a personal computer, laptop, tablet, or smartphone for wrist-worn activity tracker syncing
- • Satisfying average baseline steps/day criteria (calculated from waist-worn activity tracker data from the run-in period)
- Exclusion Criteria:
- • Non-English speaking
- • Residence in nursing home
- • Diagnosis of dementia, epilepsy, Parkinson's Disease, or diabetes with peripheral neuropathy
- • Inflammatory arthritis (rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, reactive arthritis, systemic lupus erythematosus, polymyalgia)
- • Psychological issues that preclude participation
- • Inpatient or other musculoskeletal surgery scheduled within six months following index primary TKR
- • Uses a wheelchair to ambulate (subjects who use a cane will be eligible)
- • Surgeon-documented other reason for study exclusion
- • Subject does not have regular access to a device capable of receiving email or text messages
About Brigham And Women's Hospital
Brigham and Women's Hospital (BWH) is a leading academic medical center located in Boston, Massachusetts, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As an integral part of the Partners HealthCare system, BWH combines cutting-edge medical education with a focus on patient-centered care, fostering an environment that promotes groundbreaking clinical trials across various specialties. The hospital is dedicated to translating scientific discoveries into effective treatments, making significant contributions to the fields of cardiovascular medicine, oncology, and women's health, among others. With a robust infrastructure for research and a collaborative approach, BWH aims to improve patient outcomes and enhance the overall quality of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kansas City, Kansas, United States
Boston, Massachusetts, United States
Chicago, Illinois, United States
Omaha, Nebraska, United States
Cleveland, Ohio, United States
Buffalo, New York, United States
Columbia, South Carolina, United States
Patients applied
Trial Officials
Elena Losina, Ph.D.
Principal Investigator
Brigham and Women's Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials